Published in
Springer, Clinical and Translational Oncology, 9(23), p. 1818-1826, 2021
DOI: 10.1007/s12094-021-02588-8
Links
Tools
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis
Journal article published in 2021 by
G. Metro 
,
A. Gili,
D. Signorelli,
A. De Toma,
M. Garaffa,
D. Galetta,
P. Economopoulou,
A. Friedlaender,
B. Jimenez,
A. Collazo-Lorduy,
A. Addeo ,
P. Chiarini,
C. Costa,
G. Mountzios,
F. Roila
,
A. Gili,
D. Signorelli,
A. De Toma,
M. Garaffa,
D. Galetta,
P. Economopoulou,
A. Friedlaender,
B. Jimenez,
A. Collazo-Lorduy,
A. Addeo ,
P. Chiarini,
C. Costa,
G. Mountzios,
F. Roila
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 